LDN and tDCS in Fibromyalgia

计划入组 92 人 · 首次发布于 2020 年 8 月 6 日

Low Dose Naltrexone (LDN) Immune Monitoring

计划入组 9 人 · 首次发布于 2014 年 4 月 8 日

Low Dose Naltrexone for Glioma Patients

计划入组 110 人 · 首次发布于 2011 年 2 月 25 日

LDN-071

LDN-072

LDN-214117

Lin BioScience, Inc.

China

LTN Pharmaceuticals, Inc.

United States

CHRYSEA LABS, LDA

Portugal

Novel Research Reveals UCHL1 as Therapeutic Target in Ovarian Cancer and Western Diet's Impact on Liver Cancer

Naltrexone Shows Promise in Reducing Fatigue in Primary Sjögren’s Syndrome

NIH's RECOVER-TLC Long COVID Trials Face Delays, Won't Begin Enrollment Until Summer 2026